Last reviewed · How we verify

NCT03442140

Harmonica Playing Improves Quality of Life in Patients With COPD

Completed NA Last updated 30 January 2026
What this trial tests

NA trial testing Harmonica playing in COPD in 15 participants. Completed in 1 December 2019.

Timeline
1 August 2017
Primary endpoint
1 March 2018
1 December 2019

Quick facts

Lead sponsorBaylor Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment15
Start date1 August 2017
Primary completion1 March 2018
Estimated completion1 December 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baylor Research Institute

Who can join

45 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

15 patients who have completed the Baylor Martha Foster Lung Center Pulmonary Rehabilitation Program at least six months ago will be selected to participate in a 12 week training program with six months of follow up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Baylor Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03442140.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing